Aptinyx Inc. is a biopharmaceutical company focused on discovery and development of transformative therapies for challenging neurological disorders. Aptinyx has a proven platform for discovering compounds that enhance synaptic plasticity, or strengthen the network for neural cell communication.
Market
Neurological disorders
Location
Evanston,
Illinois,
USA
Coinvestors
Adams Street Partners, Beecken Petty O'Keefe & Company, Frazier Healthcare, Goudy Park Capital, Longitude Capital, LVP Life Sciences Ventures, New Leaf Venture Partners, Northwestern University, Osage University Partners, PathoCapital